Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Unum Group | UNM | Aug 30, 2024 | 55.49 | +0.36 |
Unusual Machines | UMAC | Aug 30, 2024 | 1.63 | -7.39 |
UP Fintech A ADR | TIGR | Aug 30, 2024 | 3.64 | -6.43 |
Upbound | UPBD | Aug 30, 2024 | 33.30 | -0.12 |
Upland Software | UPLD | Aug 30, 2024 | 2.21 | +4.25 |
Upstart Holdings | UPST | Aug 30, 2024 | 42.50 | -0.70 |
Upwork | UPWK | Aug 30, 2024 | 9.64 | +0.31 |
Ur-Energy | URG | Aug 30, 2024 | 1.17 | +1.74 |
Uranium Energy | UEC | Aug 30, 2024 | 5.23 | +2.95 |
Uranium Royalty | UROY | Aug 30, 2024 | 2.19 | -0.45 |
Uranium+Nuclear Energy ETF Market Vectors | NLR | Aug 30, 2024 | 75.56 | +0.92 |
Urban Edge Properties | UE | Aug 30, 2024 | 21.15 | +1.24 |
Urban One A | UONE | Aug 30, 2024 | 2.13 | +4.41 |
Urban One D | UONEK | Aug 30, 2024 | 1.38 | +5.34 |
Urban Outfitters | URBN | Aug 30, 2024 | 36.32 | -0.87 |
urban-gro | UGRO | Aug 30, 2024 | 1.39 | +4.14 |
Urgently | ULY | Aug 30, 2024 | 0.94 | -5.09 |
UroGen Pharma | URGN | Aug 30, 2024 | 13.91 | -0.64 |
US 12 Month Oil | USL | Aug 30, 2024 | 37.64 | -2.45 |
US Anti-Beta Fund Market Neutral Quantshares | BTAL | Aug 30, 2024 | 20.18 | +0.45 |
US Bancorp | USB-R | Aug 30, 2024 | 18.75 | -0.74 |
US Brent Oil | BNO | Aug 30, 2024 | 29.95 | -2.47 |
US Commodity Index | USCI | Aug 30, 2024 | 61.04 | -0.49 |
US Copper | CPER | Aug 30, 2024 | 26.31 | +0.34 |
US Foods | USFD | Aug 30, 2024 | 59.21 | +0.05 |
US Gasoline | UGA | Aug 30, 2024 | 62.26 | -0.79 |
US Ipo Index First Trust | FPX | Aug 30, 2024 | 103.54 | +1.32 |
US Natural Gas | UNG | Aug 30, 2024 | 13.37 | -0.45 |
US Oil | USO | Aug 30, 2024 | 74.34 | -3.17 |
Usa Compression Partners LP Unit | USAC | Aug 30, 2024 | 22.51 | -0.22 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.